subject: Fda 483 Warning Letter: What It's All About [print this page] The 483 warning letter is issued by the FDA field investigator after an on-site inspection to list deficiencies in a quality system. The observations contained in every 483 are based on the inspector's interpretation of the regulations as they relate to the operational GMP quality system.
It is important to understand FDA requirements in the current enforcement climate. 83 letters are expected to increase this year, reflecting the FDA's recent staff expansion and rewrite of 483 warning letter rules to narrow response time to the new 15-day window, and the hard truth that many quality managers in pharmaceutical processing plants think they are in compliance when they are not
The FDA is responsible for regulating the safety of food, drugs, cosmetics, biological products, medical devices, and consumer products that emit radiation. It has the power to establish federal rules and regulations about these products. Compliance is the act of following these regulations.
Regulatory consulting services can help us with meeting international requirements for drugs, biologics, food, feed, dietary supplements and more. Regulatory consulting services can assist with obtaining premarket approval, stay in FDA compliance, reduce FDA compliance cost and reduce FDA compliance cost.
Compliance historically has been an expensive, although necessary, proposition. As the life science industry becomes more competitive, reducing compliance cost is as important to success as controlling costs, quality and time-to-market.
A Manufacturing Execution System (MES) helps bridge the gap between regulatory control, operational control and case management. Typically, regulatory affairs are focused on FDA compliance and clinical trials, and manufacturing operations are focused on manufacturing and quality issues. By bringing these groups together, the MES helps life science manufacturers improve manufacturing efficiency and product quality, while at the same time lowering manufacturing costs and developing products that meet FDA regulations and FDA compliance guidelines.
The FDA Quality System regulation and the basic Good Manufacturing Practices (GMP) requirements apply to all manufacturers and distributors of medical devices, including medical device kits, trays or packs, for distribution in the United States. The FDA quality system regulation applies to finished devices intended to be commercially distributed for human use unless there is an approved exemption in effect.
The FDA Quality System regulation indicates the required end results rather than specifically prescribing how manufacturers are to comply with the regulation. It is the manufacturer's responsibility to develop quality systems that appropriately applies the Quality System regulation to their specific products and operations. The FDA quality system must be monitored through audits. The analysis and use of feedback data from product acceptance, audits, complaints, repairs and other sources are necessary parts of a self-correcting quality system.
